The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study

---

Selvi Y., Atli A., Aydin A., Besiroglu L., Ozdemir P., Ozdemir O.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, vol.26, no.1, pp.51-57, 2011 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 26 Issue: 1
• Publication Date: 2011
• Doi Number: 10.1002/hup.1169
• Journal Name: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.51-57
• Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive-compulsive disorder (OCD) patients who did not show a >= 35% decrease in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) after 12-week monotherapy with selective serotonin reuptake inhibitors (SSRIs).